Health Condition 1: F315- Bipolar disorder, current episodedepressed, severe, with psychotic features Health Condition 2: F333- Major depressive disorder, recurrent, severe with psychotic symptoms Health Condition 3: F428- Other obsessive-compulsive disorder Health Condition 4: F208- Other schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA Grade 2-3 undergoing ECT
Exclusion criteria
Exclusion criteria: Patients who dose not give written inform consent. Uncooperative patients. Patients with 2nd or 3rd degree heart block or persistant bradycardia. Patients on drugs such as beta blocker or antiarrhythmic drugs. Patients with history of allergic to study drugs. Pregnant or nursing mother.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of succinylcholine induced myalgia after ECT assessed using a 4 point myalgia grading scale (0= none, 1= mild, 2= moderate, 3= sever)Timepoint: After ECT 10min, 15min, 30min, 1hr, 2hr, 4hr, 6hr, 8hr | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Severity of succinylcholine induced myalgia 2. Hemodynamic parameter(Heart rate, mean arterial pressure, Spo2%) 3. requirement of rescue analgesia 4. Adverse effectsTimepoint: After ECT 10min, 15min, 30min, 1hr, 2hr, 4hr, 6hr, 8hr | — |
Countries
India
Contacts
GMC Bhavnagar